TAG:
cpt
Automated Pap Smear Screening Expected to Build Market Share
EXPECT 1999 TO BE A PIVOTAL YEAR in automated Pap smear screening. This new technology is now poised to enter general clinical usage. As it does, an increasing volume of clinical data will make the case: either automated screening of Pap smears is clinically effective and economically justified—or…
DIANON Wins Contract, Buys Kyto Meridien Lab
CEO SUMMARY:Anatomic pathology took another forward step on the managed care battleground. DIANON Systems, Inc. gained status as a provider of anatomic pathology services under the new master agreement announced by Oxford Health Plans. DIANON’s success demonstrates that anatomic patholo…
Kaiser, SBCL To Automate Pap Smear Screening
CEO SUMMARY: Two of the country’s largest Pap screen testing organizations are preparing to introduce automated primary screening into their laboratories. NeoPath’s con- tracts with SmithKline Beecham Clinical Laboratories and Kaiser Permanente mark the beginning of a new market cycle…
Rate of Change Follows a Geometric Curve
JANUARY WAS A WILD MONTH FOR COMPANIES OFFERING automated cytology products. January opened with new CPT codes for automated cytology procedures taking effect. January closed with news that the FDA’s advisory panel, convened on January 28, recommended approval of the PMA supplement of NeoPath, Inc…
Automated Pap Screening Gains Recommendation
CEO SUMMARY: Automated cytology technology received a big boost when the FDA’s advisory panel voted to recommend that the FDA approve, with conditions, NeoPath’s AutoPap® System as a primary Pap Smear Screener. The company still awaits final FDA approval on this matter….
Neuromedical’s PAPNET® Undergoing Enhancement
CEO SUMMARY: Financial pressures and a falling stock price impelled Neuromedical Systems, Inc. to revamp its sales and marketing plan for the PAPNET® System. During 1998, expect a new sales approach that supports a product with enhanced capabilities. Neuromedical is developing overseas m…
Automated Cytology Technology To Come Into Its Own In 1998
CEO SUMMAR…
1997’s Top Ten Lab Stories Predict New Directions
CEO SUMMARY: Events during 1997 reveal that the laboratory industry continues to undergo fundamental change. Yet even amidst the industry’s downsizing, selected laboratory organizations continue to flourish. Here is THE DARK REPORT’s annual look at top stories for the year. A careful …
To Protect Pathology Profits: Understand Managed Care
CEO SUMMARY: On November 8, 1997, THE DARK REPORT convened a private symposium restricted only to pathologists. The sole purpose of this event was to identify how pathologists could preserve and enhance their income. Within the confidential setting of a plush resort in Scottsdale, Arizona…
“December 29, 1997 Intelligence: Late Breaking Lab News”
AmeriPath, Inc. is at it again. On December 19, company officials announced the acquisition of two more pathology practices. The practices are The Dermatopathology Laboratory in Pittsburgh and Laboratory Physicians in Jacksonville. More acquisition a…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.